WO2001091586A3 - Compositions de konjac mannan et de ginseng, procedes et utilisations - Google Patents

Compositions de konjac mannan et de ginseng, procedes et utilisations Download PDF

Info

Publication number
WO2001091586A3
WO2001091586A3 PCT/CA2001/000774 CA0100774W WO0191586A3 WO 2001091586 A3 WO2001091586 A3 WO 2001091586A3 CA 0100774 W CA0100774 W CA 0100774W WO 0191586 A3 WO0191586 A3 WO 0191586A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
compositions
konjac mannan
ginseng
applications
Prior art date
Application number
PCT/CA2001/000774
Other languages
English (en)
Other versions
WO2001091586A2 (fr
Inventor
Vladimir Vuksan
Original Assignee
Vladimir Vuksan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vladimir Vuksan filed Critical Vladimir Vuksan
Priority to CA2410556A priority Critical patent/CA2410556C/fr
Priority to US10/296,196 priority patent/US7326404B2/en
Priority to AU2001268858A priority patent/AU2001268858A1/en
Publication of WO2001091586A2 publication Critical patent/WO2001091586A2/fr
Publication of WO2001091586A3 publication Critical patent/WO2001091586A3/fr
Priority to US11/960,033 priority patent/US20080131531A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A21D2/18—Carbohydrates
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/36—Vegetable material
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
    • A23L19/115—Konjak; Konntaku
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

L'invention porte: sur des compositions, soit d'un mélange à base de konjac mannan, soit de ginseng, soit de konjac mannan et de ginseng américain; sur leurs utilisations dont l'abaissement de la glycémie et de la glycémie postprandiale chez les non diabétiques et diabétiques et pour le traitement de l'hyperlipidémie, de la surtension artérielle, de l'excès de NO, du syndrome X, et des maladies cardio-vasculaires, et sur différentes autres applications et procédés.
PCT/CA2001/000774 2000-05-31 2001-05-31 Compositions de konjac mannan et de ginseng, procedes et utilisations WO2001091586A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA2410556A CA2410556C (fr) 2000-05-31 2001-05-31 Compositions konjac mannan et de polysaccharides et leurs utilisations
US10/296,196 US7326404B2 (en) 2000-05-31 2001-05-31 Konjac-mannan and ginseng compositions and methods and uses thereof
AU2001268858A AU2001268858A1 (en) 2000-05-31 2001-05-31 Konjac mannan and ginseng compositions and methods and uses thereof
US11/960,033 US20080131531A1 (en) 2000-05-31 2007-12-19 Konjac Mannan and Ginseng Compositions and Methods and Uses Thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20809000P 2000-05-31 2000-05-31
CA002310513A CA2310513A1 (fr) 2000-05-31 2000-05-31 Compositions et methodes pour abaisser la glycemie
US60/208,090 2000-05-31
CA2,310,513 2000-05-31

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10/296,196 A-371-Of-International US7326404B2 (en) 2000-05-31 2001-05-31 Konjac-mannan and ginseng compositions and methods and uses thereof
US11/960,033 Division US20080131531A1 (en) 2000-05-31 2007-12-19 Konjac Mannan and Ginseng Compositions and Methods and Uses Thereof

Publications (2)

Publication Number Publication Date
WO2001091586A2 WO2001091586A2 (fr) 2001-12-06
WO2001091586A3 true WO2001091586A3 (fr) 2002-09-06

Family

ID=4166363

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2001/000774 WO2001091586A2 (fr) 2000-05-31 2001-05-31 Compositions de konjac mannan et de ginseng, procedes et utilisations

Country Status (3)

Country Link
AU (1) AU2001268858A1 (fr)
CA (1) CA2310513A1 (fr)
WO (1) WO2001091586A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10247910A1 (de) * 2002-10-14 2004-04-22 Beisel, Günther Mittel zur Erzeugung eines langanhaltenden Sättigungseffektes
WO2004056209A1 (fr) * 2002-12-19 2004-07-08 Beisel Guenther Agent contenant du ginseng destine a la creation d'un effet de satiete et a la reduction de poids
KR100728055B1 (ko) * 2005-02-24 2007-06-13 (주)바이오뉴트리젠 비만증 및 고지혈증 예방용 식품
AU2006235123A1 (en) * 2005-04-07 2006-10-19 Astrum Therapeutics Pty. Ltd. Complementary compositions to reduce blood glucose levels and treat diabetes
US8062686B2 (en) 2005-04-12 2011-11-22 InovoBiologics, Inc. Dietary supplement, and methods of use
US8597709B2 (en) 2005-04-12 2013-12-03 Inovobiologic Inc. Dietary supplement and methods of use
ATE468121T1 (de) * 2006-02-21 2010-06-15 Astrum Therapeutics Pty Ltd Zusammensetzungen zur verringerung des blutglukosespiegels und zur behandlung von diabetes
JP4771882B2 (ja) * 2006-07-21 2011-09-14 味の素ゼネラルフーヅ株式会社 糖尿病または糖尿病性合併症の治療、予防、または改善作用を有する組成物およびこれを含有する飲料
CN102885312A (zh) * 2012-10-19 2013-01-23 中科乐仁（北京）科技发展有限公司 一种增强免疫力的保健食品组合物及其制备方法
CN106943423B (zh) * 2017-03-23 2019-08-27 江苏省中医药研究院 具有调节肠道菌群结构作用的多糖组合物及其应用
CN109010694A (zh) * 2018-09-21 2018-12-18 武汉万密斋养生堂科技发展股份有限公司 一种具有降血糖功能的魔芋、茯苓多糖组合物及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048532A (en) * 1996-07-08 2000-04-11 Diaz; Jose A. Chemical composition and method for aiding the absorption, binding and elimination of undigested fat and reducing cholesterol in the human body

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048532A (en) * 1996-07-08 2000-04-11 Diaz; Jose A. Chemical composition and method for aiding the absorption, binding and elimination of undigested fat and reducing cholesterol in the human body

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
DOI K ET AL: "TREATMENT OF DIABETICS WITH DIETARY FIBERS 4. THE EFFECT OF HIGH VISCOSITY OF DIETARY FIBERS ON THE POST PRANDIAL BLOOD GLUCOSE", JOURNAL OF THE JAPAN DIABETIC SOCIETY, vol. 25, no. 3, 1982, pages 197 - 203, XP001056851, ISSN: 0021-437X *
MATSUURA M ET AL: "DIETARY FIBER (GLUCOMANNAN) AS A TEST MEAL FOR THE TREATMENT OF DIABETES MELLITUS 3. TRIAL OF GLUCO MANNAN IN NORMAL SUBJECTS", JOURNAL OF THE JAPAN DIABETIC SOCIETY, vol. 24, no. 4, 1981, pages 513 - 516, XP001056850, ISSN: 0021-437X *
NG T B ET AL: "Hypoglycemic constituents of Panax ginseng.", GENERAL PHARMACOLOGY. ENGLAND 1985, vol. 16, no. 6, 1985, pages 549 - 552, XP001083522, ISSN: 0306-3623 *
SOTANIEMI E A ET AL: "Ginseng therapy in non-insulin-dependent diabetic patients.", DIABETES CARE. UNITED STATES OCT 1995, vol. 18, no. 10, October 1995 (1995-10-01), pages 1373 - 1375, XP001083521, ISSN: 0149-5992 *
STAVRO M P ET AL: "The effect of dose and time escalation of American ginseng (Panax quinquefolium L.) on glycemic response in type 2 diabetes.", FASEB JOURNAL, vol. 14, no. 4, 15 March 2000 (2000-03-15), Annual Meeting of Professional Research Scientists: Experimental Biology 2000;San Diego, California, USA; April 15-18, 2000, pages A736, XP001084501, ISSN: 0892-6638 *
VUKSAN V ET AL: "American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals.", THE AMERICAN JOURNAL OF CLINICAL NUTRITION. UNITED STATES APR 2001, vol. 73, no. 4, April 2001 (2001-04-01), pages 753 - 758, XP001083508, ISSN: 0002-9165 *
VUKSAN V ET AL: "American ginseng improves glycemia in individuals with normal glucose tolerance: effect of dose and time escalation.", JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION. UNITED STATES 2000 NOV-DEC, vol. 19, no. 6, November 2000 (2000-11-01), pages 738 - 744, XP001084506, ISSN: 0731-5724 *
VUKSAN V ET AL: "Beneficial effects of viscous dietary fiber from konjac mannan in subjects with the insulin resistance syndrome", JOURNAL OF CLINICAL AND APPLIED RESEARCH AND EDUCATION: DIABETES CARE, vol. 23, no. 1, January 2000 (2000-01-01), pages 9 - 14, XP001056810 *
VUKSAN V ET AL: "Chronic feeding of Konjac-Mannan (KJM) fibre improves postprandial glycemia in insulin resistance.", FASEB JOURNAL, vol. 14, no. 4, 15 March 2000 (2000-03-15), Annual Meeting of Professional Research Scientists: Experimental Biology 2000;San Diego, California, USA; April 15-18, 2000, pages A727, XP001057055, ISSN: 0892-6638 *
VUKSAN V ET AL: "Konjac-Mannan (Glucomannan) improves glycemia and other associated risk factors for coronary heart disease in Type 2 diabetes", JOURNAL OF CLINICAL AND APPLIED RESEARCH AND EDUCATION: DIABETES CARE, vol. 22, no. 6, June 1999 (1999-06-01), pages 913 - 919, XP001056807 *
VUKSAN V ET AL: "Moderate supplementation of konjac mannan improve glycemia and heart disease risk factors in Type 2 diabetics", DIABETES, vol. 42, no. SUPPL 1, May 1993 (1993-05-01), pages 251A, XP001056804 *
VUKSAN V ET AL: "Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes.", DIABETES CARE. UNITED STATES SEP 2000, vol. 23, no. 9, September 2000 (2000-09-01), pages 1221 - 1226, XP001083915, ISSN: 0149-5992 *
VUKSAN VLADIMIR ET AL: "American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus.", ARCHIVES OF INTERNAL MEDICINE, vol. 160, no. 7, 10 April 2000 (2000-04-10), pages 1009 - 1013, XP001056732, ISSN: 0003-9926 *
VUKSAN VLADIMIR ET AL: "North American ginseng unequally affects postprandial glycemia in type 2 diabetic and nondiabetic individuals.", DIABETES, vol. 48, no. SUPPL. 1, 1999, 59th Scientific Sessions of the American Diabetes Association;San Diego, California, USA; June 19-22, 1999, pages A362, XP001056728, ISSN: 0012-1797 *

Also Published As

Publication number Publication date
WO2001091586A2 (fr) 2001-12-06
CA2310513A1 (fr) 2001-11-30
AU2001268858A1 (en) 2001-12-11

Similar Documents

Publication Publication Date Title
WO2001091586A3 (fr) Compositions de konjac mannan et de ginseng, procedes et utilisations
WO2005011592A3 (fr) Indazoles-o-glucosides substitues
WO2005012243A3 (fr) Indole-o-glucosides substitues
WO2005019255A8 (fr) Muteines de la lipocaline lacrymale
WO2006010557A8 (fr) Cyclenes substitues par d-glucopyranosyle-phenyle, medicaments contenant lesdits composes, leur utilisation et procede de production correspondant
WO2001090091A8 (fr) Inhibiteurs de 11-beta-hydroxy-steroide-deshydrogenase de type 1
WO2007127273A3 (fr) Procédés et compositions permettant de modifier la fonction cellulaire
WO2004096798A3 (fr) Derives de 2-acylamino-4-phenylthiazole, leur preparation et leur application en therapeutique
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
WO2003000226A3 (fr) Compositions pharmaceutiques contenant des ensembles polymere et medicament
EP1419783A3 (fr) Utilisation d'une composition contenant de l'exendin ou un dérivé et un support pharmaceutique
MX2008004734A (es) Composicion rica en leucina.
GEP20063917B (en) Pulmonary administration of chemically modified insulin
EP1561472A4 (fr) Preparation solide
WO2006044573A3 (fr) Inhibiteurs reversibles de la s-adenosyl-l-homocysteine hydrolase et leurs utilisations
WO2005079396A3 (fr) Complexes de o,o'-amidomalonate and n,o-amidomalonate platine
WO2007047351A3 (fr) Méthodes pour traiter l'hypertension chez des individus en surpoids et obèses
WO2007048027A3 (fr) Combinaison de composes organiques
CA2436540A1 (fr) Composition pharmaceutique a base d'anticholinergiques et de corticosteroides
WO2004078105A3 (fr) Composition de fondaparinux sodique de haute purete
WO2005046569A3 (fr) Composition pharmaceutique destinee au traitement du syndrome respiratoire aigue severe (sras)
CA2412789A1 (fr) Compositions destinees a ameliorer la concentration mentale
WO2005009334A3 (fr) Inhibiteurs reversibles de s-adenosyl-l-homocysteine hydrolase et leurs utilisations
WO2005051313A3 (fr) Procedes et reactifs pour le traitement, la prevention et le diagnostic d'infection par le bunyavirus
WO2003083436A3 (fr) Fragments se fixant au fibrinogene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2410556

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10296196

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP